Invention Grant
- Patent Title: Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis
-
Application No.: US14916288Application Date: 2014-09-18
-
Publication No.: US10663472B2Publication Date: 2020-05-26
- Inventor: Guillaume Monneret , Fabienne Venet , Alain Lepape , Julie Demaret , Astrid Villars-Mechin
- Applicant: BIOMERIEUX , HOSPICES CIVILS DE LYON
- Applicant Address: FR Marcy l'Etoile FR Lyons
- Assignee: BIOMERIEUX,HOSPICES CIVILS DE LYON
- Current Assignee: BIOMERIEUX,HOSPICES CIVILS DE LYON
- Current Assignee Address: FR Marcy l'Etoile FR Lyons
- Agency: Ladas & Parry LLP
- Agent Malcolm J. MacDonald
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@727a35f5
- International Application: PCT/FR2014/052318 WO 20140918
- International Announcement: WO2015/040328 WO 20150326
- Main IPC: G01N31/00
- IPC: G01N31/00 ; G01N33/53 ; G01N33/68
Abstract:
The invention provides a method of evaluating the risk of mortality in patients who present a systemic inflammatory response (SIRS) or septic syndromes, comprising measuring the expression of sCD127 in a biological sample.
Public/Granted literature
Information query
